丸激素反弹预测前列腺癌患者治疗德加利克斯的预后有利
Shuhei Kamada1, Shinichi Sakamoto1, Ryo Kinoshita1
1Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.
The Prostate
|February 27, 2024
概括
激素反弹,在初始抑制后激素水平的上升,是一种有前途的生物标志物,用于预测用德加利克斯酸盐治疗前列腺癌患者的整体存活率和癌症特异性存活率.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
背景情况:
- 调查前列腺癌的德加利克斯酸盐治疗期间丸激素 (T) 水平波动的临床意义.
- 为T确定20 ng/dL的切断值,以预测治疗结果.
研究的目的:
- 评估激素动态的预测价值,包括T反弹,对于前列腺癌患者的生存结果.
- 为了澄清T水平作为治疗德加利克斯酸盐的患者的预后因素的作用.
主要方法:
- 对120名前列腺癌患者的回顾性分析,这些患者接受了德加利克斯酸盐治疗.
- 评估最低T水平,最大T水平和T反弹 (最低T <20 ng/dL和最大T ≥20 ng/dL) 作为预测因素.
- 评估整体生存率 (OS),癌症特异性生存率 (CSS) 和无进展生存率 (PFS).
主要成果:
- 在50%的患者 (60/120) 中发生了T反弹.
- T反弹与有利的OS (p=0.0019) 和CSS (p=0.0013) 有着显著的关联,但不是PFS (p=0.92).
- 在一个子组分析中,T反弹在生化复发后预测了有利的OS和CSS.
结论:
- 通过特定的T水平值定义的丸激素反弹是预测OS和CSS的有希望的生物标志物.
- 这一发现对正在接受德加利克斯酸盐治疗的前列腺癌患者尤为重要.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Disorders of the Male Reproductive System
414
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
414
Testosterone: Functions and Regulation
648
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
648


